BTS Research News
What's new at BTS
BTS Research Earns Full AAALAC Accreditation Renewal
BTS Research Earns Full AAALAC Accreditation Renewal Continued Commitment to Excellence in Laboratory Animal Care San Diego, California – BTS Research a PharmaLegacy company is pleased to announce that the company has successfully renewed its FULL ACCREDITATION from the AAALAC International Council on Accreditation, recognizing its unwavering dedication to the highest standards in laboratory animal…
BTS Research Successfully Completes USDA Inspection with Zero Findings
BTS Research Successfully Completes USDA Inspection with Zero Findings San Diego, CA – August 28, 2024 – BTS Research, a leading contract research organization specializing in preclinical research services, is proud to announce the successful completion of its USDA inspection with zero findings. The inspection was triggered by the recent acquisition of BTS Research by…
PharmaLegacy acquires preclinical CRO BTS Research,
PharmaLegacy acquires preclinical CRO BTS Research PharmaLegacy acquires preclinical CRO BTS Research, strengthening its preclinical services and expanding laboratory operations into North America PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS Research, a San Diego-based preclinical contract research organization (CRO). As a reputable CRO providing preclinical…
BTS Research Addresses FDA Warning Letter Satisfactorily
BTS Research Addresses FDA Warning Letter Satisfactorily From the desk of the President & CEO, April 1st, 2024 BTS is very pleased to have received a satisfactory completion of the findings the FDA had issued a warning letter on October 20th 2023. The findings were originally noted during their June 27th 2022 audit, which centered around…
BTS Research Completes Corrections of FDA 483 Observations
BTS Research Completes Corrections of FDA 483 Observations From the desk of the President & CEO On July 8, 2022, U.S. Food and Drug Administration (FDA) Investigator concluded an inspection of the BTS Research facilities located in San Diego, CA and issued Inspectional Observations on the form FDA-483 that triggered a Warning Letter issued on…
COVID-19 Response
BTS Research is taking in animals for temporary housing from local vivariums BTS provides services in the following research animals: Rodents. Rabbits. Guinea pigs. Dogs NHP’s. Contact us for more details.
BTS Research Passes an FDA Bioresearch Monitoring Program Inspection for GLP Rat and Dog Toxicity Studies
BTS Research is pleased to share with its clients the results of the FDA audit which was concluded on December 4th, 2019. Following a 14-day onsite inspection, the FDA concluded their inspection of a 2-week GLP Rat Intravenous study and a 26-Week GLP Oral dog study for two of BTS’ clients. The FDA affirmed that…
BTS Research Passed USDA Inspection 2018
BTS Research is finishing 2018 on a high note BTS Research is pleased to report this year’s USDA inspection has been completed with 0 findings. Since BTS incubation in 2001, aside from minor recommendations from USDA that were addressed immediately, BTS enjoys a clean track record with all regulating agencies with no violations. Site 002…
Advanced NHP Research Capabilities: Molecular Imaging
BTS Research has partnered with BioLaurus Inc. , an advanced molecular imaging group to bring new research capabilities to our pharma research clients. The gold standard for pre-clinical research has long been the non human primate (NHP) but access to NHP and advanced research capabilities has become ever more challenging. To meet this challenge there…
BTS Research’s, Sam Abunadi President & CEO, urges the FDA to require “Clinical Trials” for Cannabis dose determination as a scheduled substance with not yet classified strands
With many cities and states now approving cannabis products, and without a doctor note, the American population at large is being invited to be a part of an uncontrolled drug influence clinical trial without a sufficiently regulated method to question the right dose determination hence consumers and non-consumers are subjected to possible danger. Now that…